Short-Term Immunosuppression Enhances Long-Term Survival of Bovine Chromaffin Cell Xenografts in Rat Cns

Xenogeneic donors, a largely untapped resource, would solve many of the problems associated with the limited availability of human donor tissue for neural transplantation. Previous work in our laboratory has revealed that xenografts of isolated bovine chromaffin cells survive transplantation into the periaqueductal gray (PAG) of immunosuppressed adult rats. Electron microscopic analysis reveals that graft sites contain healthy chromaffin cells, but do not contain host immune cells typical of graft rejection. The aim of the current study was to assess the necessary conditions for long-term survival of bovine chromaffin cell xenografts in the central nervous system (CNS). In particular, the need for short-course vs. permanent immunosuppressive therapy with cyclosporine A (CsA) for the long-term survival of grafted bovine chromaffin cells was addressed. Grafts from animals receiving continuous CsA treatment for either 3, 6, or 12 wk contained large clumps of dopamines-β-hydroxylase (DBH) positive cells in contrast to the few surviving cells observed in nonimmunosuppressed animals. In addition, grafts from animals that had CsA treatment terminated at 3 or 6 wk contained similarly large clumps of DBH-positive cells. Furthermore, short-term immunosuppression (3 wk) appeared to enhance the long-term survival of grafted cells, since clumps of DBH staining cells could still be positively identified in the host PAG at least 1 yr after transplantation. Complete rejection of graft tissue depends on several factors, such as blood–brain barrier integrity, the presence of major histocompatability complex (MHC) antigens in either the host or graft, and the status of the host immune system. By using a suspension of isolated bovine chromaffin cells, potential MHC antigen presenting cells, such as endothelial cells, are eliminated. In addition, CsA treatment may negate the immunologic consequences of increased blood–brain barrier permeability following surgical trauma by attenuating the host cell mediated response. In summary, long-term survival of isolated chromaffin cell xenografts in the rat CNS may be attained by a short-term course of CsA.

[1]  O. Lindvall.  Transplants in Parkinson's disease , 1992 .

[2]  E. García Flores.  Development of human neural transplantation. , 1992, Neurosurgery.

[3]  J. Zaia.  Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. , 1991 .

[4]  R. Little,et al.  Cyclosporine A inhibition of alloantigen presentation. , 1991, Transplantation proceedings.

[5]  W. Freed,et al.  Brain grafts and Parkinson's disease , 1991, Journal of cellular biochemistry.

[6]  N. Sigal,et al.  Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. , 1991, Transplantation proceedings.

[7]  J. Zimmer,et al.  Immunological reactions to neural grafts in the central nervous system. , 1991, Restorative neurology and neuroscience.

[8]  G. Bing,et al.  Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesions , 1990, Neuroscience.

[9]  I. Date,et al.  Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice , 1990, Brain Research.

[10]  J. Sagen,et al.  Host-graft relationships of isolated bovine chromaffin cells in rat periaqueductal grey , 1990, Journal of neurocytology.

[11]  J. Kordower,et al.  NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. , 1990, Journal of neurosurgery.

[12]  A. Fine.  Transplantation of adrenal tissue into the central nervous system , 1990, Brain Research Reviews.

[13]  J. Zimmer,et al.  Immune reactions against intracerebral murine xenografts of fetal hippocampal tissue and cultured cortical astrocytes in the adult rat. , 1990, Progress in brain research.

[14]  S. Kohsaka,et al.  Immunological rejection of grafted tissue in xenogeneic neural transplantation. , 1990, Progress in brain research.

[15]  P. Lacy,et al.  Effect of in vitro culture and cyclosporine A treatment on adrenal medulla allograft survival. , 1989, The Journal of surgical research.

[16]  I. Date,et al.  Immunological reaction and blood-brain barrier in mouse-to-rat cross-species neural graft , 1988, Brain Research.

[17]  J. Sagen,et al.  Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions , 1988, Experimental Neurology.

[18]  J. Kordower,et al.  Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Graft viability and fine structure , 1988, Experimental Neurology.

[19]  H. Winn,et al.  Brain xenografts: the effect of cyclosporin A on graft survival. , 1988, Journal of neurosurgery.

[20]  I. Date,et al.  Intraparenchymal allografts in the mouse brain in relation to immunocytochemical identification of T lymphocyte subsets , 1988, Neuroscience Letters.

[21]  J. Sagen,et al.  The fine structure of chromaffin cell implants in the pain modulatory regions of the rat periaqueductal gray and spinal cord. , 1988, Progress in brain research.

[22]  J. Antel,et al.  Rejection of fetal neocortical neural transplants by H-2 incompatible mice. , 1987, Journal of immunology.

[23]  D. Mason,et al.  The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents , 1986, Neuroscience.

[24]  H. Thoenen,et al.  Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. , 1985, The EMBO journal.

[25]  W. Fierz,et al.  Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. , 1985, Journal of immunology.

[26]  T. Yaksh.  Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing , 1985, Pharmacology Biochemistry and Behavior.

[27]  S. Geyer,et al.  IMMUNOGENETIC ASPECTS OF TRANSPLANTATION IN THE RAT BRAIN , 1985, Transplantation.

[28]  Kazunari Yoshida,et al.  Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain , 1985, Neuroscience Letters.

[29]  H. Pollard,et al.  An osmotic mechanism for exocytosis from dissociated chromaffin cells. , 1984, The Journal of biological chemistry.

[30]  Morris Pj.  The impact of Cyclosporin A on transplantation. , 1984 .

[31]  B. Kahan,et al.  Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. , 1983, Transplantation.

[32]  A. Thomson.  Immunobiology of cyclosporin A--a review. , 1983, The Australian journal of experimental biology and medical science.

[33]  F. Gage,et al.  Cross-species neural grafting in a rat model of Parkinson's disease , 1982, Nature.

[34]  R. Calne,et al.  The Use of Cyclosporin A Immunosuppression in Organ Grafting , 1982, Immunological reviews.

[35]  O. H. Viveros,et al.  Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  T. Yaksh,et al.  Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. , 1981, Anesthesiology.

[37]  J. Rossier,et al.  Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells , 1981, Nature.

[38]  T. Hexum,et al.  Opioid peptides in adrenal gland. , 1980, Life sciences.

[39]  C. Barker,et al.  Immunologically privileged sites. , 1977, Advances in immunology.

[40]  T. Yaksh,et al.  Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray , 1976, Brain Research.

[41]  P. Medawar.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.